4//SEC Filing
Blickensdoerfer Hans-Martin 4
Accession 0001209191-21-054675
CIK 0000718937other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 1:02 PM ET
Size
25.3 KB
Accession
0001209191-21-054675
Insider Transaction Report
Form 4
Blickensdoerfer Hans-Martin
VP, International Marketing
Transactions
- Sale
Common Stock
2021-09-02$157.50/sh−11,038$1,738,485→ 88,722 total - Exercise/Conversion
Common Stock Options
2021-09-01−17,573→ 871 totalExercise: $16.15From: 2019-03-15Exp: 2028-03-14→ Common Stock (17,573 underlying) - Exercise/Conversion
Common Stock Options
2021-09-02−13,484→ 0 totalExercise: $29.80From: 2019-06-14Exp: 2028-06-13→ Common Stock (13,484 underlying) - Sale
Common Stock
2021-09-01$157.61/sh−8,621$1,358,756→ 99,760 total - Exercise/Conversion
Common Stock
2021-09-01$16.15/sh+17,573$283,804→ 117,333 total - Exercise/Conversion
Common Stock
2021-09-02$29.80/sh+13,484$401,823→ 103,077 total - Sale
Common Stock
2021-09-02$157.50/sh−17,343$2,731,523→ 88,722 total - Exercise/Conversion
Common Stock Options
2021-09-02−871→ 0 totalExercise: $16.15From: 2019-03-15Exp: 2028-03-14→ Common Stock (871 underlying) - Sale
Common Stock
2021-09-01$157.61/sh−17,573$2,769,681→ 99,760 total - Exercise/Conversion
Common Stock
2021-09-02$35.98/sh+2,988$107,508→ 106,065 total - Exercise/Conversion
Common Stock
2021-09-02$16.15/sh+871$14,067→ 89,593 total - Exercise/Conversion
Common Stock Options
2021-09-02−2,988→ 18,140 totalExercise: $35.98From: 2020-03-14Exp: 2029-03-13→ Common Stock (2,988 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.56, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.72, inclusive.
- [F5]The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029.
Documents
Issuer
STAAR SURGICAL CO
CIK 0000718937
Entity typeother
Related Parties
1- filerCIK 0001488891
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 1:02 PM ET
- Size
- 25.3 KB